ADH1 has a large unmet clinical need as commonly used treatments such as active vitamin D metabolites may cause excessive activation of the renal CaSR, thereby leading to severe hypercalciuria, renal calcifications, calculi, and impaired kidney function (1, 8). Here, ADH1A is linked to Hypercalciuria.